tirzepatide in nash synergy the SYNERGY-NASH trial, researchers assessed the efficacy and safety of once-weekly tirzepatide in persons with metabolic Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis

Special thanks to Terence Kee, Sobhana Thangaraju, Liew Ian Tatt, Chieh Suai Tan Jenny Leong, Joey Kay, Ang Wei Mian, the Department of Microbiology (Lynette Oon Deborah Lai Kun Lee Lim, Lau Minyi), Pharmacy (Puay Hoon Lee Yan Ting Yeo, PharmD, Lim Rou Wei) and Infectious Diseases (Jasmine Chung) for making this study possible

Your provider reviews your full history

The oral form is approved for the same patient population as injectable Wegovy

As an alternative approach to increase cellular cholesterol content, cells were pretreated with avasimibe for 12 h (Supplementary Fig

All consultations, follow-ups, and provider check-ins are conducted virtually

Perfect for various occasions including: Daily bathing